Skip to content
Screener

Tyra Biosciences, Inc. TYRA Prepaid & Other Current

Prepaid & Other Current at other companies

Incyte logo
IncyteINCY
$253.09M-14.4%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$254.05M+43.4%
UroGen Pharma logo
UroGen PharmaURGN
$12.78M+6.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$65.65M+9.0%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$22.32M+130%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$16.1M+90.3%

Other financials

Income statement

See full
Operating income-$42.0M-31.9%
Net income-$39.3M-39.6%
EPS (diluted)-$0.64-36.2%

Balance sheet

See full
Cash & equivalents$85.0M-15.7%
Total debt$5.7M-6.9%
Total equity$387.6M+19.8%
Total assets$412.0M+20.0%

Cash flow

See full
Operating cash flow-$32.6M-27.9%
CapEx$88.0K+529%
Free cash flow-$32.7M-28.2%

Valuation

See full
Market cap$1.58B+195%
Enterprise value$1.5B+238%

Returns & leverage

See full
Return on equity-36.9%+21.1pp
Debt / equity0.0×
Current ratio20.5×-2.3×

Where this comes from

Reported directly by Tyra Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 8:03 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-220645
Line itemMarch 31, 2026December 31, 2025
Current assets:
Cash and cash equivalents$84,955$77,387
Marketable securities298,511178,616
Prepaid expenses and other current assets11,1479,447
Total current assets394,613265,450
Restricted cash8841,000
Property and equipment, net1,2151,314
Right-of-use assets5,4435,573

Item 1. Condensed Financial Statements

FAQ

What is Tyra Biosciences, Inc.'s prepaid & other current?
Tyra Biosciences, Inc. (TYRA) reported prepaid & other current of $11.15M in Q1 2026.
How has Tyra Biosciences, Inc.'s prepaid & other current changed year-over-year?
Tyra Biosciences, Inc.'s prepaid & other current increased by 98.2% year-over-year, from $5.62M to $11.15M.
What is the long-term trend for Tyra Biosciences, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s prepaid & other current has grown at a 177.9% compound annual growth rate (CAGR), from $57K to $9.45M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Tyra Biosciences, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude